Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Neuropsychiatrische problematiek bij epilepsie en verstandelijke beperking
jan 2019 | Epilepsie